Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Profit After Tax (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Profit After Tax data on record, last reported at -$1.1 million in Q2 2025.

  • For Q2 2025, Profit After Tax rose 83.81% year-over-year to -$1.1 million; the TTM value through May 2025 reached -$38.7 million, down 422.29%, while the annual FY2025 figure was -$38.7 million, 422.29% down from the prior year.
  • Profit After Tax reached -$1.1 million in Q2 2025 per LFCR's latest filing, up from -$14.8 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $15.6 million in Q1 2024 and bottomed at -$39.3 million in Q2 2023.
  • Average Profit After Tax over 5 years is -$9.9 million, with a median of -$7.8 million recorded in 2021.
  • Peak YoY movement for Profit After Tax: tumbled 4314.87% in 2022, then soared 211.03% in 2023.
  • A 5-year view of Profit After Tax shows it stood at $3.7 million in 2021, then crashed by 448.46% to -$12.8 million in 2022, then skyrocketed by 211.03% to $14.2 million in 2023, then crashed by 146.22% to -$6.6 million in 2024, then soared by 82.54% to -$1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Profit After Tax were -$1.1 million in Q2 2025, -$14.8 million in Q1 2025, and -$6.6 million in Q4 2024.